Oncotarget

Retraction:

Retraction: Decreased long intergenic noncoding RNA P7 predicts unfavorable prognosis and promotes tumor proliferation via the modulation of the STAT1-MAPK pathway in hepatocellular carcinoma

PDF  |  How to cite

Oncotarget. 2024; 15:19-19. https://doi.org/10.18632/oncotarget.28366

Metrics: PDF 501 views  |   ?  

Sijie Cheng1, Tieling Li2, Cheng Wang2, Keyu Wang3, Chengcai Lai3, Jin Yan1, Hongxia Fan1, Fang Sun1, Zhaohai Wang1, Peirui Zhang1, Linxiang Yu1, Zhixian Hong1, Guanglin Lei1, Baijun Sun1, Yuan Gao1, Zhaohui Xiao1, Xu Ji1, Ruilan Wang1, Jianzhong Wu1, Xiliang Wang2, Shaogeng Zhang1 and Penghui Yang1,3

1Beijing 302 Hospital, Beijing, 100039, China
2Chinese PLA General Hospital, Beijing, 100853, China
3State Key Laboratory of Pathogens and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, China

Published: January 16, 2024

Copyright: © 2024 Cheng et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been retracted: Multiple images in Figure 3C, which illustrates that LincRNA P7 inhibited the proliferation of HCC cells SMMC7721 and Huh7 with colony-forming assay, were found to be fraudulent duplications of images from a previously published Oncotarget paper [1] Figure 2D, which represents results of colony formation in different HCC cells Huh-6, BEL-7402 and SMMC-7721 transfected with unrelated HULC siRNA. As a result, all authors have agreed to the retraction of this paper from Oncotarget.

REFERENCE

1. Li SP, Xu HX, Yu Y, He JD, Wang Z, Xu YJ, Wang CY, Zhang HM, Zhang RX, Zhang JJ, Yao Z, Shen ZY. LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway. Oncotarget. 2016; 7:42431–46. https://doi.org/10.18632/oncotarget.9883. [PubMed]

Original article: Oncotarget. 2018; 9:36057–36066. DOI: https://doi.org/10.18632/oncotarget.23282


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28366